MEGI NYLI CBRE Global Infrastructure Megatrends Term Fund Insider Trading

Saba Capital Management sells 110,906 shares of MEGI for $1.5M at avg $13.76; fourth consecutive sale in 4 days

Saba Capital Management, L.P., a 10% owner of MEGI, executed 2 separate sales totaling 110,906 shares for $1,525,546.32 at a blended average price of $13.76 on 2026-01-13 and 2026-01-14. This transaction reduces holdings from 5,35M shares to 5.24M shares (-2.1%). Notably, this represents the fourth consecutive sale by the same insider at this ticker within four days (2026-01-06 through 2026-01-09, followed by these two sales on 2026-01-13 to 2026-01-14), a pattern of sustained liquidation rather than isolated rebalancing. The current price of $13.90 is -7.3% from the 52-week high of $15.00, and the blended transaction price of $13.76 reflects execution slightly below current levels. Without measurable 90-day outcomes available for any of the four prior same-ticker sales, the pattern of repeated dispositions over consecutive days warrants monitoring to establish whether the insider's sequence of sales precedes material weakness.

Saba Capital sells 78,470 MEGI shares (−1.4% of 5.38M holding) for $1,067,596.15 across 2 transactions

Saba Capital Management, L.P., a 10% owner, executed 2 separate sales totaling 78,470 shares for $1,067,596.15, reducing holdings from 5,463,221 shares to 5,384,751 shares. The blended average transaction price of $13.61 sits 0.8% below the current price of $13.72 and 9.2% below the 52-week high of $15.00. Saba's cross-ticker track record shows 18 prior buys against only 2 prior sells, and at the MEGI ticker specifically, these sales on 2026-01-08 and 2026-01-09 follow on the heels of two earlier sales on 2026-01-07 and 2026-01-06—all within a four-day window. The modest 1.4% reduction in position size and the minor price context (current trading near recent lows but off the 52-week bottom) provide limited directional signal, though the tight clustering of four sales in four consecutive days warrants attention to whether this reflects a deliberate portfolio adjustment or a broader shift in Saba's stance toward the fund.

Saba Capital sells 95,467 shares of MEGI across 2 transactions for $1.3M at blended $13.72, reducing stake by 1.7%

Saba Capital Management, L.P., a 10% owner, executed 2 separate sales totaling 95,467 shares for $1,309,814.70 at a blended average price of $13.72 on January 6–7, 2026. The sales reduced holdings from 5,558,688 shares to 5,463,221 shares, a decline of 1.7% relative to pre-transaction holdings. The transaction prices ($13.74 and $13.70) were modestly above the current price of $13.61, placing them near the 52-week midpoint and above recent momentum: the stock has declined 6.6% over 90 days and 0.2% over 30 days. Across Saba's cross-ticker track record, prior sell activity shows a pattern of 2 prior sells versus 18 prior buys, indicating selling is a rare event for this insider; however, outcomes for the 2 prior same-ticker sales at MEGI are not yet measurable. The sale itself is modest in scale relative to the remaining 5.46M-share position, suggesting a partial reduction rather than a material change in stance toward the fund.

Saba Capital reduces MEGI stake by 94,857 shares (1.7% of holdings) in 2 separate sales totaling $1,305,987.53

Saba Capital Management sold 19,336 shares at $13.76 on 2025-12-24 and 75,521 shares at $13.77 on 2025-12-26, reducing its position from 5.70M to 5.61M shares while the stock trades near current price of $13.78. The sales occurred near the top of the 52-week range ($11.70–$15.00) and represent a modest 1.7% reduction relative to pre-transaction holdings. As a 10% owner filing the transaction, Saba's history shows 20 prior open-market buys across all tickers—indicating a predominantly acquisitive pattern—yet this filing captures a period of net selling activity that warrants monitoring for shifts in positioning at this fund.

Saba Capital Management sells 79,400 MEGI shares (1.3% of holdings) for $1,115,026.72 across two days at $14.04–$14.09.

Saba Capital Management, L.P., a 10% owner of MEGI, executed 2 separate sales totaling 79,400 shares for $1,115,026.72 on 2025-11-06 and 2025-11-07 at a blended average price of $14.04, reducing holdings by 1.3% to 5,890,860 shares. The transactions occurred near the 52-week high of $15.00 and at a price within $0.06 of the current price of $14.10, with the stock down 3.3% over the prior 30 days. Notably, the insider has completed 3 separate sales at MEGI within a 4-day window (2025-11-03 through 2025-11-07), signaling a rapid, sequential reduction of the position. Cross-ticker historical data shows 13 prior sells versus 7 prior buys, consistent with a net-selling orientation, though outcomes on those prior sales cannot yet be assessed against the 90-day performance threshold.

Saba Capital sells 79,337 shares of MEGI across 2 transactions for $1,108,856.10; holdings reduced to 5.97M shares.

Saba Capital Management, L.P., a 10% owner, executed 2 separate sales totaling 79,337 shares for $1,108,856.10 on 2025-11-04 and 2025-11-05 at blended average price $13.98, representing a -1.3% reduction in holdings from 6.05M to 5.97M shares. The sales occurred as MEGI traded near its 52-week high, with the current price at $13.98 down -6.8% from the $15.00 52-week peak and -6.5% over the prior 30 days. Saba's cross-ticker track record shows 7 prior buys versus 13 prior sells, with no measurable timing outcomes yet available for its 2 prior MEGI-specific trades. The modest reduction in a substantial holding, executed at prices near recent highs, provides limited actionable signal without visibility into Saba's broader capital allocation activity or fund positioning constraints.

10% owner Saba Capital sold 108,100 shares of MEGI at $14.08; stock down 7.2% from 52-week high

Saba Capital Management, L.P., a 10% owner, executed a sale of 108,100 shares at $14.08 on 2025-11-03, reducing holdings by 1.8% to 6,049,597 shares. The transaction occurred while MEGI trades 7.2% below its 52-week high of $15.00 and has declined 6.6% over the trailing 30 days. Cross-ticker, Saba has an even history of 10 prior buys and 10 prior sells, but at MEGI specifically this represents a discrete data point with no prior same-ticker measurable outcomes. The current price of $13.92 is below the transaction price of $14.08, indicating the sell has not yet resulted in outperformance relative to the open-market execution.

Jeremy Anagnos buys 250 MEGI shares at $14.36; 5th purchase in ~4 months with 2 of 2 measurable prior buys showing +9.9% and +20.1% 90-day returns.

Anagnos purchased 250 shares of NYLI CBRE Global Infrastructure Megatrends Term Fund (MEGI) at $14.36 on 2025-08-01, bringing his total holdings to 28,000 shares. This purchase is the fifth open-market transaction in this security within the past four months (dating back to 2025-04-07), and follows a pattern of accumulation: his prior trades at MEGI have produced measurable 90-day returns of +9.9% and +20.1%, both outcomes representing gains after the purchase. Current price at $14.50 sits near the 52-week high of $14.95, up 6.3% over the past 90 days. The repeated purchases at this fund, combined with historical price appreciation following his entry points at this ticker, suggest the insider has identified value in this vehicle, though the small transaction size and modest position increase (+0.9%) relative to existing holdings warrants consideration of whether this reflects a routine accumulation cadence rather than a concentrated conviction signal.

Insider Jeremy Anagnos bought 250 shares of MEGI at $14.10; stock at $14.33 with 90-day gains in 4 of 4 measurable prior buys at this ticker.

Jeremy Anagnos purchased 250 shares of NYLI CBRE Global Infrastructure Megatrends Term Fund at $14.10 on 2025-07-11, increasing his position to 27,750 shares (+0.9% vs pre-transaction holdings). The purchase occurred within the fund's 52-week range ($11.70–$14.95), with the stock currently at $14.33, positioned near recent highs. His prior trade record at MEGI shows a notable pattern: across four measurable prior buy transactions at this ticker, all four generated positive 90-day returns, with the most recent completed trade (2025-04-07) yielding +20.1% over 90 days. This current buy represents his sixth transaction at MEGI over a 4-month span, indicating consistent engagement with this specific fund alongside modest positive 30-day and 90-day performance in his cross-ticker track record (15 prior buys, avg 30d return +0.7%, avg 90d return +1.3%, 50% win rate).

Jeremy Anagnos buys 235 MEGI shares at $14.00; stock now $14.12, up 6.6% in 90 days

Anagnos purchased 235 shares of MEGI at $14.00 on 2025-06-26, increasing his holdings from 27,265 to 27,500 shares (+0.9%). The purchase occurred at a price 1.2% below the current price of $14.12 and near the 52-week high of $14.95. At the same-ticker level, Anagnos has completed 5 prior purchases of MEGI dating back to December 2024; of these, the measurable 90-day outcome shows a 50% win rate (1 of 2 prior buys delivered positive 90-day returns). The most recent prior buy on 2025-05-23 has not yet had a measurable 90-day outcome. Across his broader open-market trading history (all tickers), Anagnos has posted a 90-day win rate of 45.45% with an average 90-day return of -0.4%, indicating a mixed record of timing outcomes. Current price action shows the fund has rallied 6.6% over the past 90 days and 1.7% over the past 30 days.